Palantir Technologies Inc. CEO Alex Karp defended Anthropic chief Dario Amodei during a company all-hands meeting, even while continuing to criticize rival AI labs. “I’ve spent a lot of time with Dario,” Karp said in the company’s all-hands meeting that...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Joby Aviation shares have been cut nearly in half over the past year, yet analysts are quietly upgrading their outlooks ahead of a catalyst window packed with international launches, defense contracts, and a pivotal earnings report that could reset the stock's trajectory.
The second-largest U.S. bank provided an update to investors about the consent order issued by the OCC in 2024, saying a resolution may include monetary penalties.
SoFi just posted record revenue and a 50% earnings jump, yet the stock cratered anyway and sits near its worst levels of the year. The path back to $25 demands more than strong growth numbers.
Nuclear energy could be a $10 trillion global opportunity.
A European court rejected Broadcom's attempt to block regulators from demanding U.S.-based VMware legal documents.
A huge lending pipeline now faces a profitability test
The US manufacturing sector continued to grow in July, with Institute for Supply Management data ind
Throughout the market rotations and volatility of 2026, one group of stocks has been crushing the S&P 500 this year.
The company develops software for plasma-based manufacturing.
COP heads into Q2 earnings with higher oil prices lifting prospects, while volatility, unhedged output and operational disruptions pose risks.
Wall Street is assessing whether Starlink's profits can finance SpaceX's rapidly expanding artificial-intelligence and space investments.
Microsoft stock has been on a roll following its recent earnings report.
Investors who exited high-profile hyperscaler stocks because of surging AI capex may be overlooking an important point: Tech giants' cloud computing backlogs support their strong spending plans.
Beware the ides of August, which on Wall Street describes the poor performance traders tend to expect for the month. The Nasdaq Composite wasn't as close to a fresh record, but climbed 2.2% during the session.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Meta's heavy AI capex spending could eat up all its free cash flow this year -- and next year, too.
The AI spending boom is becoming so large so quickly that it's hitting an important metric watched by investors: free cash flow.
Leidos’ latest Navy contract will build on its work since 2021 and will help improve operational capabilities, bolster information-sharing security, and boost technology adoption for the Hopper Global Communications Center.
Baycrest Hospital and Sunnybrook Health Sciences Centre are rolling out a joint Oracle Health EHR platform across hospital and ambulatory clinics in Ontario. The project focuses on improving care coordination, clinician workflow, and patient experiences across multi facility health systems. This customer win expands Oracle Health’s presence in mission critical healthcare IT and supports digitization of clinical operations. For investors tracking NYSE:ORCL, this move underlines Oracle’s push...
Sportradar (SRAD) shares sank 16% amid heavy trading after the company reported Monday that it swung
Johnson & Johnson (NYSE:JNJ) received FDA authorization for its OTTAVA robotic surgical system. The company is moving ahead with the commercial launch of OTTAVA as its first table integrated, soft tissue robotic platform. This marks Johnson & Johnson's entry into the competitive surgical robotics market with a differentiated system design. For investors watching Johnson & Johnson, the OTTAVA approval adds a new dimension to the MedTech story. Surgical robotics has become a focus area for...
Visa’s latest deal could signal a new era in fighting digital scams as artificial intelligence-enabled fraud spreads. The payments giant plans to buy BioCatch, a provider of fraud intelligence technology, for $2.4 billion in cash. Visa said the addition of BioCatch will complement its current security efforts and help clients better protect themselves and their customers from the growing threat of account takeovers, scams, money mules, and application fraud.
More than eight years after Boeing organized the maiden flight of the 737 MAX 7, the aircraft has won certification, US authorities announced Monday.Monday's announcement marks Boeing's first new aircraft certified since the safety problems that have engulfed the company in recent years.
Micron's semiconductor megaproject is reshaping property values around Syracuse, and retired homeowners on fixed incomes now face a tax question most of them have never had to ask before. Two state programs could change the math, but only if you know how each one counts your income.
Amazon just handed investors a historic earnings blowout, and three ETFs built on top of the stock are racing higher in completely different directions. Which one you held this week made all the difference.
Merck & Co., Inc. (NYSE:MRK) outlined its HIV treatment and prevention strategy at an investor event following the International AIDS Conference, highlighting Phase III results for a once-weekly oral HIV regimen and its plans for a monthly oral pre-exposure prophylaxis, or PrEP, candidate. Comp
AMD heads into its August 4 earnings report riding a massive AI-fueled surge, but a demanding valuation and fresh insider selling raise the question of whether the rally has legs or a stumble is coming.
Cipher Digital's Q2 results may show data-center progress and stronger growth visibility, but mining exposure, construction spending and financing costs loom.
Snowflake and CareDx received favorable reviews from Wall Street firms, following better-than-expected second-quarter prints and bullish momentum across AI products, respectively.